Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Accueil  >  All News

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Age : 53
Public asset : 72,367,408 USD
Biography : Currently, Mark D. McLaughlin is Chairman for QUALCOMM, Inc.
The feature you requested does not exist. However, we suggest the following feature:

AbbVie : Correction to AbbVie Earnings Article

share with twitter share with LinkedIn share with facebook
10/30/2020 | 09:51am EDT

AbbVie Inc.'s third-quarter revenue from its immunology portfolio was $5.79 billion, a 14.8% increase year over year. That result included revenue from AbbVie's Humira medication of $5.14 billion, a figure that rose 4.1% year over year. "AbbVie Logs 3Q Sales Growth on Higher Immunology, Oncology Results," published at 8:07 a.m. ET, incorrectly said that immunology revenue increased 4.1%, to $5.14 billion.

(END) Dow Jones Newswires

10-30-20 0950ET


share with twitter share with LinkedIn share with facebook
Prev.1  2  3  4  5   6  7  8  9  10Next